Volume 9, Number 12—December 2003
Research
Mycobacterium tuberculosis Beijing Genotype1
Table 2
N | % Drug resistant (no. of patients with drug resistance)a |
|||||||
---|---|---|---|---|---|---|---|---|
Any drug | Isoniazid | Rifampicin | Streptomycin | Pyrazinamide | Ethambutol | MDRb | ||
Danish |
||||||||
Beijing |
16 |
12.5 (2) |
12.5 (2) |
6.3 (1) |
12.5 (2) |
0.0 (0) |
6.3 (1) |
6.3 (1) |
Other |
1,623 |
10.2 (165) |
3.1 (50) |
0.12 (2) |
3.6 (58) |
5.5 (89) |
0.0 (0) |
0.0 (0) |
p |
0.7 |
0.09 |
0.03 |
0.1 |
1.0 |
0.01 |
0.01 |
|
Immigrants |
||||||||
Beijing |
78 |
20.5 (16) |
9.0 (7) |
0 (0) |
16.7 (13) |
1.3 (1) |
1.3 (1) |
0.0 (0) |
Other |
2,086 |
17.2 (359) |
7.5 (157) |
0.72 (15) |
13.6 (284) |
1.3 (27) |
0.96 (20) |
0.58 (12) |
p |
0.4 |
0.7 |
1.0 |
0.4 |
1.0 |
0.5 |
1.0 |
|
Overall |
||||||||
Beijing |
94 |
19.2 (18) |
9.6 (9) |
1.1 (1) |
16.0 (15) |
1.1 (1) |
2.1 (2) |
1.1 (1) |
Other |
3,709 |
14.1 (524) |
5.6 (207) |
0.46 (17) |
9.2 (342) |
3.1 (116) |
0.54 (20) |
0.32 (12) |
p | 0.2 | 0.1 | 0.4 | 0.05 | 0.5 | 0.1 | 0.3 |
aDrug resistance data missing for 41 persons.
bMDR, multidrug resistant.
1Troels Lillebaek was responsible for the grant preparation, study design, execution, data analysis, and writing. Asger Dirksen and Åse B. Andersen supervised all parts of the study and contributed, with Judith Glynn and Kristin Kremer, critical revisions of the paper.
Page created: February 09, 2011
Page updated: February 09, 2011
Page reviewed: February 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.